BARICICH, ALESSIO
 Distribuzione geografica
Continente #
AS - Asia 1.240
NA - Nord America 792
SA - Sud America 465
EU - Europa 158
AF - Africa 24
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.684
Nazione #
SG - Singapore 828
US - Stati Uniti d'America 756
BR - Brasile 407
CN - Cina 202
VN - Vietnam 74
HK - Hong Kong 32
DE - Germania 28
IN - India 25
IT - Italia 24
AR - Argentina 22
GB - Regno Unito 20
CA - Canada 16
RU - Federazione Russa 16
EC - Ecuador 12
FR - Francia 12
MX - Messico 12
ZA - Sudafrica 12
UZ - Uzbekistan 11
NL - Olanda 10
TR - Turchia 10
AT - Austria 9
ES - Italia 9
BD - Bangladesh 8
ID - Indonesia 8
MA - Marocco 7
PL - Polonia 7
PY - Paraguay 7
JP - Giappone 6
UA - Ucraina 5
VE - Venezuela 5
CO - Colombia 4
IQ - Iraq 4
KZ - Kazakistan 4
SE - Svezia 4
CL - Cile 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
PK - Pakistan 3
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
FI - Finlandia 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
HN - Honduras 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
KI - Kiribati 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
PA - Panama 1
QA - Qatar 1
SI - Slovenia 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 2.684
Città #
Singapore 283
The Dalles 216
Dallas 134
Ashburn 91
Shanghai 88
Beijing 55
Hong Kong 31
São Paulo 31
Ho Chi Minh City 30
Los Angeles 26
Rio de Janeiro 15
Milan 14
New York 13
Prineville 13
Fort Worth 12
Hanoi 10
Montreal 10
Tashkent 9
Atlanta 8
Belo Horizonte 7
Boston 7
Denver 7
Guayaquil 7
Lauterbourg 7
Orem 7
Warsaw 7
Charlotte 6
Chennai 6
Düsseldorf 6
Fortaleza 6
Haiphong 6
Mexico City 6
Recife 6
Tokyo 6
Chicago 5
Council Bluffs 5
Curitiba 5
London 5
Marília 5
Porto Alegre 5
Quito 5
Amsterdam 4
Ankara 4
Anápolis 4
Brasília 4
Brooklyn 4
Buffalo 4
Campinas 4
Caxias do Sul 4
Johannesburg 4
Maceió 4
Manchester 4
Ninh Bình 4
Nuremberg 4
Phoenix 4
Poplar 4
San Francisco 4
Springfield 4
Stockholm 4
São José dos Campos 4
Vienna 4
Biên Hòa 3
Buenos Aires 3
Cape Town 3
Caratinga 3
Delhi 3
Goiânia 3
Guarulhos 3
Itajaí 3
Manaus 3
Munich 3
Niterói 3
Osasco 3
Praia Grande 3
Salvador 3
Santa Clara 3
Santa Luzia 3
Santo André 3
Sorocaba 3
Águas Lindas de Goiás 3
Agadir 2
Almirante Tamandaré 2
Ann Arbor 2
Araguaína 2
Assago 2
Baghdad 2
Baku 2
Bologna 2
Butiá 2
Campo Grande 2
Campos dos Goytacazes 2
Caracas 2
Caruaru 2
Casablanca 2
Ciudad del Este 2
Comodoro Municipality 2
Currais Novos 2
Diadema 2
Duque de Caxias 2
Ecatepec 2
Totale 1.398
Nome #
ROLE OF EARLY BOTULINUM TOXIN TYPE A INJECTION IN THE TREATMENT OF PATIENTS WITH POSTSTROKE SPASTICITY: PRELIMINARY RESULTS OF AN OBSERVATIONAL STUDY 84
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 71
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 62
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 39
Capitolo "Strumenti di cura: Programma farmacologico" in: Foti C, Monticone M. "Manuale di medicina fisica e riabilitativa". EDRA, Milano, 2021 38
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 37
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 36
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 35
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 35
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 35
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 35
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 34
Variations of muscle activity patterns in free weight versus flywheel resistance front squat: a pilot study 33
Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials 33
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 33
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? 33
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 33
Ageing, functioning patterns and their environmental determinants in the spinal cord injury (SCI) population: A comparative analysis across eleven European countries implementing the International Spinal Cord Injury Community Survey 33
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 33
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 32
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 32
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 31
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 30
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 30
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 30
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 30
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 30
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 29
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE 29
Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic 29
Editorial: Long term disability in neurological disease: A rehabilitation perspective 29
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 28
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 27
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 27
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 26
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 26
Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study 26
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 26
Administration of type a botulinum toxin after total hip replacement 26
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 25
RE: Impact of instrumental analysis of stiff knee gait on treatment appropriateness and associated costs in stroke patients 25
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 24
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 24
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 24
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 24
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 24
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 24
IS THE OUTCOME OF DIAGNOSTIC NERVE BLOCK RELATED TO SPASTIC MUSCLE ECHO INTENSITY? A RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH SPASTIC EQUINOVARUS FOOT 24
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin 23
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 23
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 23
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 23
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 23
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 23
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 23
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 23
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial 22
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 22
Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations 22
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial 22
Short-wave diathermy for spastic equinus foot in chronic stroke patients: a proof-of-concept pilot study 22
Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study 22
Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case–Control Study 22
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 22
Peripheral facial nerve palsy: how effective is rehabilitation? 22
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 22
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 22
Chronic stroke: an oxymoron or a challenge for rehabilitation? 22
Post-stroke spasticity as a condition: A new perspective on patient evaluation 22
Sarcopenic dysphagia: a narrative review 21
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 21
Sensor based assessment of turning during instrumented Timed Up and Go Test for quantifying mobility in chronic stroke patients 21
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects 21
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis 21
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 20
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 20
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection 20
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 20
Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials 20
People with Spinal Cord Injury in Italy 20
Is the Silfverskiöld Test a valid tool for evaluating calf muscles spastic overactivity in patients with stroke? A retrospective observational study 19
The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A 19
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial 19
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 19
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis 19
Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study 19
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 18
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 18
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 18
Ultrasound-guided injection of botulinum toxin type a for piriformis muscle syndrome: A case report and review of the literature 18
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 18
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 18
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 18
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 18
Efficacy of a Hip Flexion Assist Orthosis in Adults With Hemiparesis After Stroke 18
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 17
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 17
Early botulinum toxin type a injection for post-stroke spasticity: A longitudinal cohort study 16
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 16
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 16
Totale 2.616
Categoria #
all - tutte 19.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.439 0 0 208 71 24 165 74 75 233 302 144 143
2025/20261.368 425 279 210 250 133 71 0 0 0 0 0 0
Totale 2.807